TOP TIERMARKET NEWSWIRE
News & sentiment

EUPRAXIA PHARMACEUTI Equity (EPRX) — News & AI sentiment

EUPRAXIA PHARMACEUTI Equity (EPRX) news roundup. 3 stories in the past week, 6 over 30 days. Average 30-day sentiment is 61.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 61/100
30d stories
6
avg sentiment 61.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

EPRX news in the last 24 hours, 7 days, 30 days and 90 days

How much EPRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowEPRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days361/100EPRX headlines →
Last 30 days661.3/100EPRX headlines →
Last 90 days1457.9/100EPRX headlines →

Latest stories on EPRX

2d ago
Wedbush initiates Eupraxia Pharmaceuticals stock with Outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
2d ago
Sep 12
Sep 8
Sep 3
Aug 17
Aug 17
Aug 13
Eupraxia Pharmaceuticals reports Q2 results
Seeking Alpha34 · bearishearnings
Aug 11
Aug 11
Aug 11
Jul 13
Jul 7
Jun 19
May 28
Open EPRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →